Keywords: bayer, rises, fda, panel, recommends, xarelto, post-surgery

Bayer rises 9% as FDA panel recommends Xarelto for post-surgery VTE prevention

Article | 30 March 2009

Print This

An expert panel convened by the US Food and Drug Administration has recommended Bayer's Xarelto (rivaroxaban) for approval. Shares in ...

Enjoying this article? To continue reading you need to login or subscribe.

Subscribe now
for unlimited access to all articles

Subscriptions are £60 per month, pay as you go.
Find out more details.

Already a subscriber? Click here to log in